Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Sotorasib CAS No.2296729-00-3
Sotorasib CAS No.2296729-00-3
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2958 | 50mg | 470.00 | + Add to cart |
|
| R-R-2958 | 100mg | 830.00 | + Add to cart |
|
|
|
||||
Product description
Sotorasib (AMG-510)/CAS No.2296729-00-3 is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors.
| Appearance | N/A |
|---|---|
| Molecular Weight | 561.00 |
| Purity | >90% |
| CAS | 2296729-00-3 |
| Formula | C30H30F2N6O3 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of Sotorasib CAS No.2296729-00-3 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
